Winette van der Graaf: Two papers in the New England Journal of Medicine in one week

Winette van der Graaf shared a post on their LinkedIn:

”Extremely proud and grateful for their efforts to bring neoadjuvant immunotherapy to patients with melanoma in the NADINA study Christian Blank and CRC in the NICHE-2 Myriam Chalabi. Two papers in the New England Journal of Medicine in one week. What a wonderful group of medical oncologists at The Netherlands Cancer Institute!”

Source: Winette van der Graaf/LinkedIn

Winette van der Graaf is the President of the European Organization for Research and Treatment of Cancer (EORTC). She is a professor and the head of medical oncology Department at the Netherlands Cancer Institute (Amsterdam), Professor of Oncology at Erasmus MC (Rotterdam).

Prior to that, she was a professor at Institute of Cancer Research and Honorary Consultant at Royal Marsden Hospital (London, UK), Professor and Head of Medical Oncology Department at the Radboud University Nijmegen Medical Centre.

Dr. van der Graaf is a Board member of the European Cancer Organisation (ECO), Board member of the Connective Tissue Oncology (CTOS). She was the Chairperson of the EORTC Soft Tissue and Bone Sarcoma Group.